We have studied the regulation of the key regulatory enzyme of the cholesterol biosynthetic pathway, 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMG-CoA reductase). We will focus on the regulated degradation of HMG-CoA reductase, an integral membrane protein of the endoplasmic reticulum. We expect that our studies will yield fundamental insights into the role of degradation in regulating this enzyme and cholesterol homeostasis. More generally, we also anticipate that our work will describe a mechanism for degradation of membrane proteins of the endoplasmic reticulum. As a rationale for our studies, we consider the accelerated degradation of HMG-CoA reductase in response to regulatory molecules as a two-part process: 1) reductase itself as the target of regulatory molecules and the target for proteolysis; and 2) the proteolysis system responsible for reductase degradation. We also have a simple, undoubtedly too simple, working hypothesis that reductase binds cholesterol within the membrane domain, and undergoes some structural change which makes it more susceptible to a constitutive protease(s) within the endoplasmic reticulum. Our experiments are designed to confirm or reject parts or all of this hypothesis.
In Specific Aim 1 we refine our mutagenesis studies in the regions of membrane spans-2 and 6 which preliminary data suggest are critical regions within the reductase membrane domain for a cholesterol response. We have significantly improved a novel method for demonstrating cholesterol binding to the membrane domain of reductase and will now try to correlate loss of sterol responsiveness of various mutants with loss of sterol binding.
In Specific Aim 2 we analyze proteolytic fragments of reductase to determine a proteolytic cleavage site(s) within the membrane domain which is likely in the span-8 region. We will also extend our mutagenesis analysis of the span-8 region since we have shown that mutants in this region are resistant to proteolysis.
In Specific Aim 3, we will isolate and characterize mutants in the degradation process of CHO cells using FACS-based detection of a chimeric protein, HMGFP, consisting of the membrane domain of reductase, HM, linked to Green Fluorescent Protein, GFP.
Specific Aim 4 relies on a novel in vitro assay for reductase degradation and resolution/reconstitution to biochemically define the protease(s) necessary for reductase degradation in the endoplasmic reticulum.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Physiological Chemistry Study Section (PC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Schools of Arts and Sciences
United States
Zip Code
Moriyama, T; Wada, M; Urade, R et al. (2001) 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum. Arch Biochem Biophys 386:205-12
Cheng, H H; Xu, L; Kumagai, H et al. (1999) Oligomerization state influences the degradation rate of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 274:17171-8
Moriyama, T; Sather, S K; McGee, T P et al. (1998) Degradation of HMG-CoA reductase in vitro. Cleavage in the membrane domain by a membrane-bound cysteine protease. J Biol Chem 273:22037-43
Meigs, T E; Sherwood, S W; Simoni, R D (1995) Farnesyl acetate, a derivative of an isoprenoid of the mevalonate pathway, inhibits DNA replication in hamster and human cells. Exp Cell Res 219:461-70
Kumagai, H; Chun, K T; Simoni, R D (1995) Molecular dissection of the role of the membrane domain in the regulated degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 270:19107-13
Bradfute, D L; Simoni, R D (1994) Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl-coenzyme A reductase levels. J Biol Chem 269:6645-50
Sherwood, S W; Kung, A L; Roitelman, J et al. (1993) In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal. Proc Natl Acad Sci U S A 90:3353-7
Inoue, S; Sharma, R C; Schimke, R T et al. (1993) Cellular detoxification of tripeptidyl aldehydes by an aldo-keto reductase. J Biol Chem 268:5894-8
Roitelman, J; Olender, E H; Bar-Nun, S et al. (1992) Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum. J Cell Biol 117:959-73
Inoue, S; Simoni, R D (1992) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase and T cell receptor alpha subunit are differentially degraded in the endoplasmic reticulum. J Biol Chem 267:9080-6

Showing the most recent 10 out of 23 publications